Search results
Results from the Tech24 Deals Content Network
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [8][9]
Updated September 24, 2024 at 9:29 AM. Americans will soon be able to order free COVID-19 test kits from the federal government to be delivered to their homes. The program, offered through the ...
Free at-home COVID-19 tests are now available for families across the nation. As of Thursday, families are now able to obtain up to four free COVID-19 tests through the U.S. Department of Health ...
Sobeys was founded in Stellarton, Nova Scotia by John W. Sobey, a former carpenter, in 1907 as a meat delivery business. In 1921, Sobey's son, Frank, became a partner of the company and added six new grocery stores serving the Pictou County and Antigonish County regions. In 1946, Sobey's opened its first supermarket in New Glasgow after ...
September 16, 2024 at 4:35 PM. 'Vaccine fatigue' blamed as roughly half of people in US will skip COVID and flu shots this year. A growing number of U.S. adults are hesitant to get recommended ...
The facility set a goal of supplying COVID‑19 vaccines to nearly 100 low-to-middle income countries that could not afford them. COVAX sought to fundraise US$6.8 billion to purchase and deliver vaccines to participating countries in proportion to their populations. [ 32 ]